Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers
Open Access
- 12 January 2022
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 75, 103805
- https://doi.org/10.1016/j.ebiom.2021.103805
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Highly Sensitive and Specific Multiplex Antibody Assays To Quantify Immunoglobulins M, A, and G against SARS-CoV-2 AntigensJournal of Clinical Microbiology, 2021
- The Productivity Requirements of Implementing a Medical Scribe ProgramAnnals of Internal Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineThe New England Journal of Medicine, 2020
- SARS-CoV-2 Seroprevalence and Antibody Kinetics Among Health Care Workers in a Spanish Hospital After 3 Months of Follow-upThe Journal of Infectious Diseases, 2020
- Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospitalNature Communications, 2020
- A serological assay to detect SARS-CoV-2 seroconversion in humansNature Medicine, 2020
- U1 snRNP regulates cancer cell migration and invasion in vitroNature Communications, 2020
- Welcome to the TidyverseThe Journal of Open Source Software, 2019
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2008